T1	PROC 46 60	ENSAYO CLÍNICO
#1	AnnotatorNotes T1	C0008976; Clinical Trials; Research Activity
T2	CHEM 74 86	DEXAMETASONA
#2	AnnotatorNotes T2	C0011777; dexamethasone; Organic Chemical · Pharmacologic Substance
T3	CHEM 94 111	METILPREDNISOLONA
#3	AnnotatorNotes T3	C0025815; methylprednisolone; Hormone · Organic Chemical · Pharmacologic Substance
T4	PROC 118 128	PREVENCIÓN
#4	AnnotatorNotes T4	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T5	DISO 132 162	NAUSEA Y VÓMITO POSTOPERATORIO
#5	AnnotatorNotes T5	C0520909; Postoperative Nausea and Vomiting; Sign or Symptom
T6	PROC 168 183	COLECISTECTOMÍA
#6	AnnotatorNotes T6	C0008320; Cholecystectomy procedure; Therapeutic or Preventive Procedure
T7	PROC 218 308	ENSAYO CLÍNICO UNICÉNTRICO, DOBLE CIEGO, ALEATORIZADO, CONTROLADO, EN DOS GRUPOS PARALELOS
T8	PROC 315 331	EVALUAR EFICACIA
T9	PROC 338 348	PREVENCIÓN
#7	AnnotatorNotes T9	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T10	DISO 355 386	NAUSEA Y VÓMITO POSTOPERATORIOS
#8	AnnotatorNotes T10	C0520909; Postoperative Nausea and Vomiting; Sign or Symptom
T11	CHEM 390 402	DEXAMETASONA
#9	AnnotatorNotes T11	C0011777; dexamethasone; Organic Chemical · Pharmacologic Substance
T12	CHEM 410 427	METILPREDNISOLONA
#10	AnnotatorNotes T12	C0025815; methylprednisolone; Hormone · Organic Chemical · Pharmacologic Substance
T13	PROC 431 471	CIRUGÍA DE COLECISTECTOMÍA LAPAROSCÓPICA
T14	PROC 784 798	consentimiento
#11	AnnotatorNotes T14	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T15	DISO 507 537	Nausea y vómito postoperatorio
#12	AnnotatorNotes T15	C0520909; Postoperative Nausea and Vomiting; Sign or Symptom
T16	PROC 543 558	colecistectomía
#13	AnnotatorNotes T16	C0008320; Cholecystectomy procedure; Therapeutic or Preventive Procedure
T17	PROC 638 653	colecistectomía
#14	AnnotatorNotes T17	C0008320; Cholecystectomy procedure; Therapeutic or Preventive Procedure
T18	DISO 839 846	alergia
#15	AnnotatorNotes T18	C1527304; Allergic Reaction; Pathologic Function
T19	CHEM 863 871	fármacos
#16	AnnotatorNotes T19	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T20	DISO 909 925	nausea o vómitos
T21	DISO 928 937	cinetosis
#17	AnnotatorNotes T21	C0026603; Motion Sickness; Disease or Syndrome
T22	PROC 1031 1050	tratamiento crónico
#18	AnnotatorNotes T22	C0023977; Long-term care; Health Care Activity (?)
T23	CHEM 1055 1063	opioides
#19	AnnotatorNotes T23	C0242402; Opioids; Hazardous or Poisonous Substance · Organic Chemical · Pharmacologic Substance | C0376196; Opiates; Hazardous or Poisonous Substance · Organic Chemical · Pharmacologic Substance
T24	CHEM 1065 1086	fármacos antieméticos
T25	CHEM 1089 1100	corticoides
#20	AnnotatorNotes T25	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T26	CHEM 1128 1149	fármacos psicoactivos
#21	AnnotatorNotes T26	C0033978; Psychotropic Drugs; Pharmacologic Substance
T27	CHEM 1152 1168	antihistamínicos
#22	AnnotatorNotes T27	C0019590; Histamine Antagonists; Organic Chemical · Pharmacologic Substance
T28	PROC 1193 1200	cirugía
#23	AnnotatorNotes T28	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T29	PROC 1231 1245	consentimiento
#24	AnnotatorNotes T29	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T30	Date 13 17	2019
T31	Time 148 162	POSTOPERATORIO
#25	AnnotatorNotes T31	C0032790; Postoperative Period; Temporal Concept
T33	Time 371 386	POSTOPERATORIOS
#26	AnnotatorNotes T33	C0032790; Postoperative Period; Temporal Concept
T35	Time 523 537	postoperatorio
#27	AnnotatorNotes T35	C0032790; Postoperative Period; Temporal Concept
T37	LIVB 596 604	Paciente
#28	AnnotatorNotes T37	C0030705; Patients; Patient or Disabled Group
T38	Age 605 623	mayores de 18 años
T40	LIVB 670 679	pacientes
#29	AnnotatorNotes T40	C0030705; Patients; Patient or Disabled Group
T41	LIVB 825 834	Pacientes
#30	AnnotatorNotes T41	C0030705; Patients; Patient or Disabled Group
T42	LIVB 883 892	Pacientes
#31	AnnotatorNotes T42	C0030705; Patients; Patient or Disabled Group
T43	LIVB 938 947	Pacientes
#32	AnnotatorNotes T43	C0030705; Patients; Patient or Disabled Group
T45	LIVB 988 997	Pacientes
#33	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group
T46	Age 998 1016	menores de 18 años
T47	LIVB 1017 1026	pacientes
#34	AnnotatorNotes T47	C0030705; Patients; Patient or Disabled Group
T48	Duration 1043 1050	crónico
#35	AnnotatorNotes T48	C0205191; chronic; Temporal Concept
T49	LIVB 1101 1110	Pacientes
#36	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T50	Duration 1172 1179	las 24h
T51	LIVB 1201 1210	Pacientes
#37	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T32	Neg_cue 1211 1223	incapaces de
A1	Assertion T29 Negated
A2	Status T18 History_of
A3	Status T20 History_of
A4	Status T21 History_of
A5	Status T26 History_of
A6	Status T27 History_of
#38	AnnotatorNotes T8	C1707887; Efficacy Study; Research Activity
#39	AnnotatorNotes T13	C0162522; Cholecystectomy, Laparoscopic; Therapeutic or Preventive Procedure
#40	AnnotatorNotes T20	C0027498; Nausea and vomiting; Sign or Symptom
#41	AnnotatorNotes T24	C0003297; Antiemetics; Pharmacologic Substance 
T34	Quantifier_or_Qualifier 475 482	URGENTE
A7	Assertion T34 Negated
#42	AnnotatorNotes T34	C0439609; Urgent; Qualitative Concept
T36	Quantifier_or_Qualifier 562 569	urgente
A8	Assertion T36 Negated
#43	AnnotatorNotes T36	C0439609; Urgent; Qualitative Concept
T39	Quantifier_or_Qualifier 657 664	urgente
A9	Assertion T39 Negated
#44	AnnotatorNotes T39	C0439609; Urgent; Qualitative Concept
T44	Quantifier_or_Qualifier 187 194	URGENTE
A10	Assertion T44 Negated
#45	AnnotatorNotes T44	C0439609; Urgent; Qualitative Concept
T52	Neg_cue 184 186	NO
T53	Neg_cue 472 474	NO
T54	Neg_cue 559 561	no
T55	Neg_cue 654 656	no
T56	Neg_cue 952 954	no
T57	Observation 955 973	quieran participar
A11	Assertion T57 Negated
#46	AnnotatorNotes T57	C0600109; Willing; Finding
R1	Used_for Arg1:T3 Arg2:T4	
R2	Used_for Arg1:T2 Arg2:T4	
R3	Before Arg1:T4 Arg2:T5	
R4	Overlap Arg1:T5 Arg2:T31	
R5	After Arg1:T5 Arg2:T6	
R6	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T44	
R7	Negation Arg1:T52 Arg2:T44	
R8	Before Arg1:T9 Arg2:T10	
R9	Overlap Arg1:T10 Arg2:T33	
R10	Used_for Arg1:T11 Arg2:T9	
R11	Used_for Arg1:T12 Arg2:T9	
R12	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T34	
R13	Negation Arg1:T53 Arg2:T34	
R14	Before Arg1:T13 Arg2:T10	
R15	After Arg1:T15 Arg2:T16	
R16	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T36	
R17	Negation Arg1:T54 Arg2:T36	
R18	Overlap Arg1:T15 Arg2:T35	
R19	Has_Age Arg1:T37 Arg2:T38	
R20	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T39	
R21	Negation Arg1:T55 Arg2:T39	
R22	Experiences Arg1:T37 Arg2:T17	
T58	Observation 728 735;752 768	aceptar su participación
#47	AnnotatorNotes T58	C1302239; Patient consented to clinical trial; Finding
R24	Overlap Arg1:T58 Arg2:T14	
R25	Causes Arg1:T19 Arg2:T18	
R26	Experiences Arg1:T41 Arg2:T18	
R27	Experiences Arg1:T41 Arg2:T19	
R28	Experiences Arg1:T42 Arg2:T20	
R29	Experiences Arg1:T42 Arg2:T21	
R31	Negation Arg1:T56 Arg2:T57	
R32	Has_Age Arg1:T45 Arg2:T46	
R33	Experiences Arg1:T47 Arg2:T22	
R34	Has_Duration_or_Interval Arg1:T23 Arg2:T48	
R35	Has_Duration_or_Interval Arg1:T24 Arg2:T48	
R36	Has_Duration_or_Interval Arg1:T25 Arg2:T48	
R37	Used_for Arg1:T23 Arg2:T22	
R38	Used_for Arg1:T24 Arg2:T22	
R39	Used_for Arg1:T25 Arg2:T22	
R40	Before Arg1:T26 Arg2:T28	
R41	Before Arg1:T27 Arg2:T28	
R42	Overlap Arg1:T27 Arg2:T50	
R43	Overlap Arg1:T26 Arg2:T50	
R44	Experiences Arg1:T49 Arg2:T26	
R45	Experiences Arg1:T49 Arg2:T27	
R46	Negation Arg1:T32 Arg2:T29	
A12	Experiencer T41 Patient
A13	Experiencer T42 Patient
A14	Experiencer T43 Patient
A15	Experiencer T45 Patient
A16	Experiencer T47 Patient
A17	Experiencer T49 Patient
A18	Experiencer T51 Patient
A19	Experiencer T37 Patient
A20	Status T17 Future
A21	Experiencer T40 Patient
